CF Therapeutics Development Network Coordinating Center   Report issue

Foundation Phase 1 Phase 2 Phase 4
Founded: Bethesda MD United States (1955)

Organization Overview

First Clinical Trial
2004
NCT00097773
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

azithromycin (zithromax) (2 trials)

tobramycin (nebcin) (2 trials)

Drugs in Phase 2 Trials (6)

chlorhexidine (hibitane) (1 trial)

ciprofloxacin (cipro) (1 trial)

minocycline (minocin) (1 trial)

mupirocin (bactroban) (1 trial)

rifampin (1 trial)

trimethoprim (1 trial)

Drugs in Phase 1 Trials (1)

curcuma longa (1 trial)

Drugs in Other Trials (1)

sodium chloride (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystic Fibrosis (Phase 4)

Fibrosis (Phase 4)

Lung Diseases (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Staphylococcal Infections (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 10